Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Becton Dickinson and Company (BDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 60,887,628
  • Shares Outstanding, K 266,420
  • Annual Sales, $ 12,093 M
  • Annual Income, $ 1,100 M
  • 36-Month Beta 1.07
  • Price/Sales 5.02
  • Price/Cash Flow 16.15
  • Price/Book 4.00

Price Performance

See More
Period Period Low Period High Performance
1-Month
213.95 +8.14%
on 12/29/17
231.38 unch
on 01/17/18
+9.91 (+4.47%)
since 12/15/17
3-Month
202.73 +14.13%
on 10/18/17
231.38 unch
on 01/17/18
+28.30 (+13.94%)
since 10/17/17
52-Week
169.19 +36.75%
on 01/24/17
231.38 unch
on 01/17/18
+57.95 (+33.42%)
since 01/17/17

Most Recent Stories

More News
BD Announces Webcast of Annual Meeting of Shareholders

BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 23, 2018,...

BDX : 231.37 (+1.24%)
BD's CE Mark and Check-Point's Screening Test to Fight CPO

BD (BDX)-Check-Points' advanced bacterial screening assay will help lower mortality rates caused by AMR.

HUM : 275.75 (+2.07%)
BDX : 231.37 (+1.24%)
BIO : 252.64 (+1.42%)
NEOG : 58.73 (-0.32%)
BD Statement on FDA Warning Letter for Preanalytical Systems Business Unit

BD (Becton, Dickinson and Company) (NYSE: BDX) issued the following statement in response to receiving a warning letter from the U.S. Food and Drug Administration for its Preanalytical Systems business...

BDX : 231.37 (+1.24%)
BD Announces Live Webcast Of First Fiscal Quarter Earnings Conference Call

BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its first fiscal quarter 2018 earnings conference call on Tuesday, February 6, 2018, at 8:00 a.m. (ET)....

BDX : 231.37 (+1.24%)
FDA warns Becton Dickinson & Company of significant violations of the law as part of ongoing investigation into lead testing issues

The U.S. Food and Drug Administration today issued a warning letter to Becton Dickinson (BD) & Company that cited several violations of federal law, including marketing significantly modified versions...

BDX : 231.37 (+1.24%)
Becton Dickinson Rises 1.55% on Heavy Volume: Watch For Potential Pullback

Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $221.60 to a high of $225.00. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of...

BDX : 231.37 (+1.24%)
Look for Shares of Becton Dickinson to Potentially Pullback after Yesterday's 1.55% Rise

Becton Dickinson (NYSE:BDX) traded in a range yesterday that spanned from a low of $221.60 to a high of $225.00. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of...

BDX : 231.37 (+1.24%)
BD Announces Commencement of Offer to Repurchase its 3.000% Notes Due 2026

BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that, following its acquisition of C. R. Bard, Inc. ("Bard"), which was consummated on December 29, 2017, BD has commenced an offer to repurchase...

BDX : 231.37 (+1.24%)
BD to Present at the 36th Annual J. P. Morgan Healthcare Conference

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the 36th Annual J. P. Morgan Healthcare Conference on Tuesday, January...

BDX : 231.37 (+1.24%)
Blog Exposure - Becton Dickinson Completes Acquisition of C.R. Bard

LONDON, UK / ACCESSWIRE / January 03, 2018 / Active-Investors.com has just released a free research report on Becton Dickinson & Co. (NYSE: BDX) ("BD"). If you want access to this report all you need to...

BDX : 231.37 (+1.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

Becton, Dickinson & Company (BD) is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories....

See More

Key Turning Points

2nd Resistance Point 234.47
1st Resistance Point 232.92
Last Price 231.37
1st Support Level 228.28
2nd Support Level 225.20

See More

52-Week High 231.38
Last Price 231.37
Fibonacci 61.8% 207.62
Fibonacci 50% 200.29
Fibonacci 38.2% 192.95
52-Week Low 169.19

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.